Furthermore, various lines of evidence indicate that, in addition to abrogating the tumor-suppressor functions of wild-type p53, the common types of cancer-associated p53 mutations also provide the mutant protein with new activities that may induce tumor progression and are commonly described as gain-of-function mutations [49]. The gene discussed is TP53; the disease is neoplasm.